title: Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply.
authors.affiliation: aKarolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine bKarolinska Institutet, Department of Medicine Solna, Cardiology Unit, Stockholm, Sweden cDivision of Hypertension, CHUV, Lausanne, Switzerland dKarolinska Institutet, Department of Medicine Solna, Clinical Pharmacology Unit, Stockholm, Sweden.
authors.forename: Thomas
authors.initials: T
authors.lastname: Kahan
authors.forename: Jonas H
authors.initials: JH
authors.lastname: Schwieler
authors.forename: Håkan
authors.initials: H
authors.lastname: Wallén
authors.forename: Jürg
authors.initials: J
authors.lastname: Nussberger
authors.forename: Paul
authors.initials: P
authors.lastname: Hjemdahl
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects*; D005080:Exercise Test; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy*; D008297:Male; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors